Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Men’s Health Update Covers New BPH, Prostate Cancer Treatments

  • - Urology / Nephrology News
  • Feb 23, 2011
  • Comments
  • Viewed: 4005
Tags: | benign prostatic hyperplasia | bph | chemotherapy | focused ultrasound surgery foundation |

CHARLOTTESVILLE, VA (February 22, 2011) - The Focused Ultrasound Surgery Foundation has released a special men’s heath update in its February 2011 online newsletter.

According to the update, tremendous progress being made in developing new minimally-invasive and highly precise treatments for two conditions that afflict millions of men worldwide - prostate cancer and benign prostatic hyperplasia (BPH).

By offering increased precision, the new treatments are expected to greatly reduce incontinence and impotence, which are common side effects associated with prostate procedures.

Through a series of video interviews and accompanying text (see links below), the update describes clinical trials in which new devices are treating early stage prostate cancer patients:

- - Sunnybrook Health Sciences Centre in Toronto has completed the first clinical trial of its new transurethral device and is planning several more in-house patient studies.

- - In coming months, Profound Medical, Inc. will begin enrolling patients at two U.S. sites in a clinical trial of its transurethral device, which is based on thermal ultrasound technology licensed from Sunnybrook.

- - InSightec, Ltd. is enrolling patients in an international, multi-center clinical trial of its new prostate treatment system, which uses a transrectal applicator to deliver MR-guided focused ultrasound treatments.

The report also spotlights preclinical research projects that are using MR-guided focused ultrasound to treat BPH and to improve delivery of chemotherapy to advanced prostate tumors:

- - Collaborators at Stanford University and the University of California San Francisco have developed a transurethral MR-guided focused ultrasound device that could revolutionize the treatment of BPH.

- - Foundation-funded research at Fox Chase Cancer Center has shown that pulsed MR-guided focused ultrasound enhances the delivery of chemotherapy to prostate tumors.

Click here to access the Foundation’s men’s health update.

About the Focused Ultrasound Surgery Foundation
Driven by the desire to save lives, alleviate suffering and prevent disability, the Focused Ultrasound Surgery Foundation is devoted to advancing one of modern medicine’s most promising and game-changing technologies, noninvasive magnetic resonance-guided focused ultrasound (FUS).

Founded in 2006 and based in Charlottesville, Virginia, the Foundation is a high-performance, not-for-profit organization with global reach and an entrepreneurial spirit. To accelerate the availability and reimbursement of FUS treatments, we host symposia and workshops, fund research and fellowships, support the establishment of FUS Centers of Excellence, promote patient awareness and education, and serve as the nexus of a collaborative research network consisting of sites and investigators around the world. Our work is made possible by contributions from individuals, foundations and corporations.

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

ultrasound1 - complex diverticula1 - congenital urinary tract defects1 - short-term hormone therapy1 - vaginal wall1 - harvard medical school2 - cihi1 - lupus nephritis3 - ovulatory cycle1 - risk of kidney failure1 - medullary sponge kidney2 - halpin foundation1 - fish oil supplements1 - aggressive cancers1 - optn1 - canadian medical association journal2 - prostate mri guidelines1 - adhd1 - laparoscopic nephrectomy1 - ultrasound examination1 - american society of clinical oncology1 - urinary calculi3 - thiazides1 - urinary disease1 - kidney stone surgery1 - early kidney damage1 - urethritis2 - regular hemodialysis1 - uterine2 - escherichia coli1 -